That trade-off may soon change. New clinical trial data suggests a once-daily pill called zasocitinib may provide the clear ...

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety ...

"I was very ashamed. I felt like everywhere people were judging me," Amber Dean tells PEOPLE, recalling when her symptoms were at their worst ...

"Walking around with this very visible, very robust ailment has a pretty tremendous impact on your mental health," Maddox ...

Switching to the carnivore diet transformed a man’s skin from being covered in psoriasis plaques to clean and clear. MMA fighter and YouTuber Chad Mendes had suffered from painful plaque psoriasis ...

Add Yahoo as a preferred source to see more of our stories on Google. Since revealing her plaque psoriasis diagnosis in 2015, La La Anthony has become a powerful voice for those living with the ...

84% of adolescents with moderate-to-severe plaque psoriasis treated with investigational icotrokinra achieved clear or almost clear skin (IGA 0/1) at Week 16 ICONIC-LEAD is the first ever Phase 3 ...

Filing based on four Phase 3 studies that met all primary and co-primary endpoints. This unprecedented data package includes head-to-head superiority comparisons versus deucravacitinib, adolescent ...

Having a support system of family and friends is an important part of anyone’s life, but especially for someone living with psoriasis. Many turn to their partners as someone to lean on throughout ...

Confused between eczema and psoriasis? Experts explain how these skin conditions differ in symptoms, causes, and treatment.

ICONIC-LEAD is the first ever Phase 3 registrational study in moderate-to-severe plaque psoriasis to assess safety and efficacy of a systemic therapy in adolescents and adults simultaneously 84% of ...